Chemoradiation induces upregulation of immunogenic cell death-related molecules together with increased expression of PD-L1 and galectin-9 in gastric cancer
Abstract Surgery alone or combined with chemo- and/or radiation therapy remains the primary treatment for gastric cancer (GC) to date and immunotherapeutic tools such as monoclonal antibodies are only slowly being implemented. This is partly due to the fact that the immune microenvironment in GC dur...
Guardado en:
Autores principales: | S. H. Petersen, L. F. Kua, S. Nakajima, W. P. Yong, K. Kono |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2021
|
Materias: | |
Acceso en línea: | https://doaj.org/article/2d376157ea7b4de7a0d8620adade5ed4 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Galectin-9 interacts with PD-1 and TIM-3 to regulate T cell death and is a target for cancer immunotherapy
por: Riyao Yang, et al.
Publicado: (2021) -
Advanced glycation endproducts link inflammatory cues to upregulation of galectin-1 in diabetic retinopathy
por: Atsuhiro Kanda, et al.
Publicado: (2017) -
Galectin expression profiling identifies galectin-1 and Galectin-9Δ5 as prognostic factors in stage I/II non-small cell lung cancer.
por: Iris A Schulkens, et al.
Publicado: (2014) -
Increased expression of TAZ and associated upregulation of PD-L1 in cervical cancer
por: Yanyan Han, et al.
Publicado: (2021) -
Galectin-9 expression correlates with therapeutic effect in rheumatoid arthritis
por: Jiao Sun, et al.
Publicado: (2021)